GeneDx Holdings Corp - Warrants (22/07/2026)
WGSWW
Get informed when a big investor buys or sells
+ FollowMarket Cap$0
Close$
$-140.29
2226892.1% downside
Current Fair Value
2226892.1% downsideOvervalued by 2226892.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | - |
|---|---|
| Enterprise Value | - |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.73 |
| Beta | 2.07 |
| Outstanding Shares | 29,335,126 |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | -19.6 |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 13, 2026
EPS Estimate
$-0.01
Average shareholder expectationRevenue Estimate
$112.45 M
Average shareholder expectationNext Earnings Call
Expected Date
August 17, 2026
EPS Estimate
$-0.19
Average shareholder expectationRevenue Estimate
$111.01 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | 214,1060% |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 11.01%▼ 0.58% |
|---|---|
| Total Invested | $25,998▼ 83.35% |
| Investors Holding | 14▼ 2.00% |
ESG Score
No data
About
No data